The development of BridgeDb is as modular as BridgeDb itself. In particular, these teams exist:

  1. Java library developers
  2. Creators of the identifier mapping databases
    1. Genes and Proteins (Based on Ensembl & EnsemblGenomes)
    2. Metabolites (Based on HMDB, ChEBI, and Wikidata)
    3. Interactions (Based on Rhea)
    4. Gene-Variant (Ensembl and dnSNP)

Development team

The following groups (in alphabetical order) are contributing to the development of the BridgeDb world (current or past):

  • Gladstone Institutes: Alex Pico, Anders Riutta
  • Heriot Watt University: Alasdair Gray
  • Maastricht University: Jonathan Mélius, Egon Willighagen, Anwesha Bohler, Martijn van Iersel, Thomas Kelder,  Christ Leemans, Denise Slenter, Chris Evelo
  • University of Manchester: Christian Brenninkmeijer, Stian Soiland-Reyes, Ian Dunlop, Carole Goble
  • Others: Isaac Ho, Jianjiong Gao

Funding and sustainability

BridgeDb has been funded over the years as part of many projects, including: the Open PHACTS project, OpenRiskNet, EU-ToxRisk, NanoCommons, ELIXIR Implementation Studies MolData1 and MolData2 (2016 and 2017) and Metabolomics (2018), and FAIRplus. 

Sustainability is further ensured by the Open Science nature and the continued dependence of other projects on BridgeDb. Furthermore, people involved continuously push a standardized, FAIR identifier mapping database in other data integration projects, encouraging broader sustainability.